Advertisement
Screener

ENZO BIOCHEM, INC. Patents: Applications Rejected

ENZO BIOCHEM, INC. Patent Applications Rejected

30 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2024-11-12: Application 18865197; Invention BLOCKCHAIN-BASED BIOLOGICAL SAMPLE STORAGE; Applicant ENZO BIOCHEM, INC.; Status Abandoned -- Failure to Respond to an Office Action.
  • 2023-07-28: Application 18361073; Invention SPHINGOSINE PATHWAY MODULATING COMPOUNDS FOR THE TREATMENT OF CANCERS; Applicant ENZO BIOCHEM, INC.; Status Abandoned -- Failure to Respond to an Office Action.
  • 2023-07-26: Application 18359211; Invention Compositions for Preparing Regulatory T-Cell Compositions for the Treatment of Autoimmune Disease; Applicant ENZO BIOCHEM, INC.; Status Abandoned -- Failure to Respond to an Office Action.
  • 2021-12-15: Application 17551340; Invention USE OF ORGANIC CATIONIC COMPOUNDS TO ACCELERATE NUCLEIC ACID HYBRIDIZATION, SYNTHESIS, AND AMPLIFICATION; Applicant Enzo Biochem, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2024-11-1218865197BLOCKCHAIN-BASED BIOLOGICAL SAMPLE STORAGEENZO BIOCHEM, INC.Abandoned -- Failure to Respond to an Office ActionUS20250336488A1
Hamid ERFANIAN
Adel PERALTA
Rich PALADINO
United States
United States
United States
HAYNES, DAWN TRINAH
2023-07-2818361073SPHINGOSINE PATHWAY MODULATING COMPOUNDS FOR THE TREATMENT OF CANCERSENZO BIOCHEM, INC.Abandoned -- Failure to Respond to an Office ActionUS20240024259A1
Elazar RABBANI
James J. DONEGAN
United States
United States
SZNAIDMAN, MARCOS L
2023-07-2618359211Compositions for Preparing Regulatory T-Cell Compositions for the Treatment of Autoimmune DiseaseENZO BIOCHEM, INC.Abandoned -- Failure to Respond to an Office ActionUS20230364145A1
Robert NUSSENBLATT
Baoying LIU
Lai WEI
Elazar RABBANI
James J. DONEGAN
United States
United States
United States
United States
United States
HOWARD, ZACHARY C
2021-12-1517551340USE OF ORGANIC CATIONIC COMPOUNDS TO ACCELERATE NUCLEIC ACID HYBRIDIZATION, SYNTHESIS, AND AMPLIFICATIONEnzo Biochem, Inc.Abandoned -- Failure to Respond to an Office ActionUS20230002805A1
Elazar Rabbani
Jack Coleman
United States
United States
CHUNDURU, SURYAPRABHA
2021-10-1217498834METHODS OF TREATING AUTOIMMUNE DISEASEEnzo Biochem, Inc.Abandoned -- Failure to Respond to an Office ActionUS20220023402A1
Robert Nussenblatt
Baoying Liu
Lai Wei
Elazar Rabbani
James J. Donegan
United States
United States
United States
United States
United States
EWOLDT, GERALD R
2021-05-0417307202COMPREHENSIVE AND COMPARATIVE FLOW CYTOMETRY-BASED METHODS FOR IDENTIFYING THE STATE OF A BIOLOGICAL SYSTEMEnzo Biochem, Inc.Abandoned -- Failure to Respond to an Office ActionUS20210301357A1
Elazar Rabbani
James J. Donegan
Andrew Stewart L'Huillier
United States
United States
United States
GRAY, JESSICA
2021-03-2917215182AFFINITY TAG NUCLEIC ACID AND PROTEIN COMPOSITIONS AND PROCESSES FOR USING SAMEEnzo Biochem, Inc.Abandoned -- Failure to Respond to an Office ActionUS20210214767A1
Elazar Rabbani
Jannis G. Stavrianopoulos
James J. Donegan
Wayne Patton
Juan Carcamo
Jack Coleman
United States
United States
United States
United States
United States
United States
WHISENANT, ETHAN C
2021-01-0417140257AFFINITY TAG NUCLEIC ACID AND PROTEIN COMPOSITIONS AND PROCESSES FOR USING SAMEEnzo Biochem, Inc.Abandoned -- Failure to Respond to an Office ActionUS20210164017A1
Elazar Rabbani
Jannis G. Stavrianopoulos
James J. Donegan
Wayne Patton
Juan Carcamo
United States
United States
United States
United States
United States
WHISENANT, ETHAN C
2020-11-0217086514MONOAZO DYES WITH CYCLIC AMINE AS FLUORESCENCE QUENCHERSEnzo Biochem, Inc.Abandoned -- Failure to Respond to an Office ActionUS20210079225A1
Zaiguo Li
Praveen Pande
Natarajan Raju
United States
United States
United States
RILEY, JEZIA
2020-09-2217027761SPHINGOSINE PATHWAY MODULATING COMPOUNDS FOR THE TREATMENT OF CANCERSEnzo Biochem, Inc.Abandoned -- Failure to Respond to an Office ActionUS20210000766A1
Elazar Rabbani
James J. Donegan
United States
United States
SZNAIDMAN, MARCOS L
2020-09-0917015115Compositions for Preparing Regulatory T-Cell Compositions for the Treatment of Autoimmune DiseaseEnzo Biochem, Inc.Abandoned -- Failure to Respond to an Office ActionUS20210069247A1
Robert Nussenblatt
Baoying LIU
Lai WEI
Elazar RABBANI
James J. DONEGAN
United States
United States
United States
United States
United States
EWOLDT, GERALD R
2020-08-3117006952IMMUNOMODULATORY COMPOSITIONS AND METHODS OF USE THEREOFEnzo Biochem, IncAbandoned -- After Examiner's Answer or Board of Appeals DecisionUS20210041456A1
Ante Tocilj
Jack Coleman
Elazar Rabbani
James J. Donegan
United States
United States
United States
United States
BELYAVSKYI, MICHAIL A
2020-07-0616920773NUCLEIC ACID PROBES FOR IN SITU HYBRIDIZATIONENZO BIOCHEM, INC.Abandoned -- After Examiner's Answer or Board of Appeals DecisionUS20200332348A1
ELAZAR RABBANI
JAMES J. DONEGAN
JACK COLEMAN
MAURIZIO MAURO
United States
United States
United States
United States
LU, FRANK WEI MIN
2020-04-2116853792DIGALLIC ACID FOR REDUCTION OF INFLAMMATORY CYTOKINE ACTIVITYENZO BIOCHEM, INCAbandoned -- Failure to Respond to an Office ActionUS20200360392A1
Elazar Rabbani
Xiaofeng Li
Dakai Liu
Yazhou Zhang
Richard Jin
Riddhi Bhattacharyya
Wei Cheng
James J. Donegan
United States
United States
United States
United States
United States
United States
United States
United States
HOWELL, THEODORE R
2020-03-2616830357SPHINGOSINE PATHWAY MODULATING COMPOUNDS FOR THE TREATMENT OF CANCERSEnzo Biochem, Inc.Abandoned -- Failure to Respond to an Office ActionUS20200222341A1
Elazar Rabbani
James J. Donegan
United States
United States
SZNAIDMAN, MARCOS L
2019-06-1016435981METHOD FOR PROMOTING WOUND HEALING BY ADMINISTERING A COMPOUND WHICH BINDS LDL-RECEPTOR-RELATED PROTEIN (LRP) LIGAND BINDING DOMAINENZO BIOCHEM, INC.Abandoned -- Failure to Respond to an Office ActionUS20190350936A1
Elazar Rabbani
Xiaofeng Li
Dakai Liu
Yazhou Zhang
Richard Jin
Riddhi Bhattacharyya
Wei Cheng
James J. Donegan
United States
United States
United States
United States
United States
United States
United States
United States
HOWELL, THEODORE R
2019-01-2916260232REDUCED BACKGROUND IMMUNOASSAY PLATESEnzo Biochem, Inc.Abandoned -- Failure to Respond to an Office Action
Elazar Rabbani
United States
LIMBAUGH, KATHRYN ELIZABETH
2018-07-1916039620IMMUNOMODULATORY COMPOSITIONS AND METHODS OF USE THEREOFEnzo Biochem, Inc.Abandoned -- Failure to Respond to an Office ActionUS20180328943A1
Ante Tocilj
Jack Coleman
Elazar Rabbani
James J. Donegan
United States
United States
United States
United States
BELYAVSKYI, MICHAIL A
2018-05-0915974759METHOD FOR PROMOTING WOUND HEALING BY ADMINISTERING A COMPOUND WHICH BINDS LDL-RECEPTOR-RELATED PROTEIN (LRP) LIGAND BINDING DOMAINENZO BIOCHEM, INC.Abandoned -- Failure to Respond to an Office ActionUS20180344742A1
Elazar RABBANI
XIAOFENG LI
DAKAI LIU
YAZHOU ZHANG
RICHARD JIN
RIDDHI BHATTACHARYYA
WEI CHENG
JAMES J. DONEGAN
United States
United States
United States
United States
United States
United States
United States
United States
HOWELL, THEODORE R
2018-04-2615963441DYES FOR ANALYSIS OF PROTEIN AGGREGATIONEnzo Biochem, Inc.Abandoned -- Failure to Respond to an Office ActionUS20180273759A1
Wayne Forrest Patton
Sergiy M. Yarmoluk
Praveen Pande
Vladyslava Kovalska
Lijun Dai
Kateryna Volkova
Jack Coleman
Mykhaylo Losytskyy
Anthony Ludlam
Anatoliy Balanda
Dee Shen
United States
Ukraine
United States
Ukraine
United States
Ukraine
United States
Ukraine
United States
Ukraine
United States
HAQ, SHAFIQUL
2017-05-0215584108IMMUNE MODULATION FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATIONEnzo Biochem, Inc.Abandoned -- Failure to Respond to an Office ActionUS20170232084A1
Robert Nussenblatt
Baoying Liu
Lai Wei
Elazar Rabbani
James J. Donegan
United States
United States
United States
United States
United States
EWOLDT, GERALD R
2017-03-3015474271COMPREHENSIVE AND COMPARATIVE FLOW CYTOMETRY-BASED METHODS FOR IDENTIFYING THE STATE OF A BIOLOGICAL SYSTEMEnzo Biochem, IncAbandoned -- Failure to Respond to an Office ActionUS20170204481A1
Elazar RABBANI
James J. Donegan
Andrew Stewart L'Huillier
United States
United States
United States
MAHATAN, CHANNING S
2016-11-2915363187METHODS FOR INHIBITING CELLULAR UPTAKE OF THE ANTHRAX LETHAL TOXIN (LT) PROTEIN COMPLEXENZO BIOCHEM, INC.Abandoned -- Failure to Respond to an Office ActionUS20170071950A1
Xiaofeng Li
DAKAI LIU
YAZHOU ZHANG
RICHARD JIN
RIDDHI BHATTACHARYYA
WEI CHENG
United States
United States
United States
United States
United States
United States
RICCI, CRAIG D
2016-10-0715288087METHOD FOR PROMOTING WOUND HEALING BY ADMINISTERING A COMPOUND WHICH BINDS LDL-RECEPTOR-RELATED PROTEIN (LRP) LIGAND BINDING DOMAINENZO BIOCHEM, INC.Abandoned -- Failure to Respond to an Office ActionUS20170020883A1
ELAZAR RABBANI
XIAOFENG LI
DAKAI LIU
YAZHOU ZHANG
RICHARD JIN
RIDDHI BHATTACHARYYA
WEI CHENG
JAMES J. DONEGAN
United States
United States
United States
United States
United States
United States
United States
United States
LANDSMAN, ROBERT S
2016-06-2215189531TOLERIZING TREATMENTS FOR AUTOIMMUNE DISEASEEnzo Biochem, Inc.Abandoned -- Failure to Respond to an Office ActionUS20160296565A1
Robert Nussenblatt
Baoying Liu
Lai Wei
Elazar Rabbani
James J. Donegan
United States
United States
United States
United States
United States
EWOLDT, GERALD R
2015-02-0214611702COMPREHENSIVE AND COMPARATIVE FLOW CYTOMETRY-BASED METHODS FOR IDENTIFYING THE STATE OF A BIOLOGICAL SYSTEMEnzo Biochem, Inc.Abandoned -- Failure to Respond to an Office ActionUS20160177396A1
Elazar Rabbani
James J. Donegan
Andrew Stewart L'Huillier
United States
United States
United States
MAHATAN, CHANNING S
2013-06-1813920964DIAGNOSIS AND TREATMENT OF VIRAL DISEASESENZO BIOCHEM, INC.Abandoned -- Failure to Respond to an Office ActionUS20140193423A1
GERARD NUOVO
VIRGINIA NIVAR
United States
United States
JIANG, DONG
2013-05-0113874732SCLEROSTIN AND THE INHIBITION OF WNT SIGNALING AND BONE FORMATIONENZO BIOCHEM, INC.Abandoned -- Failure to Respond to an Office ActionUS20130251735A1
DAN DIANQING WU
XIAOFENG LI
United States
United States
BORIN, MICHAEL L
2013-04-2613871730METHODS OF IDENTIFYING AND USING IMMUNE-MODULATING PEPTIDESENZO BIOCHEM, INC.Abandoned -- Failure to Respond to an Office ActionUS20140322188A1
ROBERT NUSSENBLATT
BAOYING LIU
LAI WEI
ELAZAR RABBANI
JAMES J. DONEGAN
United States
United States
United States
United States
United States
EWOLDT, GERALD R
2013-03-1413826747VITAMIN D ASSAYSENZO BIOCHEM, INC.Abandoned -- Failure to Respond to an Office ActionUS20140273021A1
JOHN F. ZIELINSKI
RORY J. OLSON
MICHAEL C. MULLENIX
United States
United States
United States
GROSSMAN, ANDREA S